Background and methodology of MONITOR-GCSF, a pharmaco-epidemiological study of the multi-level determinants, predictors, and clinical outcomes of febrile neutropenia prophylaxis with biosimilar granulocyte-colony stimulating factor filgrastim
Authors:
- Matti AaproMAMatti Aapro
- Heinz LudwigHLHeinz Ludwig
- Nadia RosencherNRNadia Rosencher
- Matthew TurnerMTMatthew Turner
- MinKyoung SongMSMinKyoung Song
- Karen MacDonaldKMKaren MacDonald
- Christopher LeeCLChristopher Lee
- Michael MuenzbergMMMichael Muenzberg
- Ivo AbrahamIAIvo Abraham
- 31 March 2011
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 77 (3) , 184-197
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Strategies for minimizing complications of neutropenia: Prophylactic myeloid growth factors or antibioticsCritical Reviews in Oncology/Hematology, 2009
- The impact of new European Organisation for Research and Treatment of Cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patientsEuropean Journal of Cancer, 2008
- Role of colony stimulating factors (CSFs) in solid tumours: Results of an expert panelCritical Reviews in Oncology/Hematology, 2007
- Impact of Primary Prophylaxis With Granulocyte Colony-Stimulating Factor on Febrile Neutropenia and Mortality in Adult Cancer Patients Receiving Chemotherapy: A Systematic ReviewJournal of Clinical Oncology, 2007
- EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumoursEuropean Journal of Cancer, 2006
- Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysisAnnals of Oncology, 2005
- Risk Models for Predicting Chemotherapy-Induced NeutropeniaThe Oncologist, 2005
- The colony-stimulating factors: use to prevent and treat neutropenia and its complicationsExpert Opinion on Biological Therapy, 2004
- A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropeniaSupportive Care in Cancer, 2004
- Chemotherapy‐induced neutropeniaCancer, 2004